Health and Healthcare

Targacept: Late Day Volume Surge Deserves Attention

by H.S. Ayoub
BioHealth Investor.com

Shares of Targacept (TRGT) traded heavily, and suddenly, late during Tuesday’s trading. While the stock price popped along with the volume surge, shares ended down 3 pennies at $8.90. The day’s total volume was more than 5x the 3-month daily average.

Targacept engages in the design, discovery, and development of drugs for the treatment of multiple diseases and disorders of the central nervous system. As of December 31, 2006, the company had four clinical-stage product candidates and three preclinical product candidates in its product portfolio.

Targacept’s market cap is a tiny $170 million with more than $54 million in cash holdings, and $1.4 million in debt as last reported by Yahoo!Finance.

I caught the volume surge in time before the end of trading and purchased shares at $9.25. While shares ended regular hours trading at $8.90, a trade of $9.37 was registered after hours at 6:04 pm, again according to Yahoo!.

Shares of Targacept did not make BHI’s BioWatch Alert list however, as a price jump of at least %5 is required before the end of regular hours trading.

But Wednesday’s trading session should prove interesting for Targacept shares. Keep a close eye on this stock tomorrow!

Source: BioHealth Investor.com

Essential Tips for Investing: Sponsored

A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.

Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.